MedPath
NMPA Approval

Losartan Potassium Tablets

H20140914

April 7, 2020

H20140914

Drug Information

氯沙坦钾片

片剂

50mg

化学药品

April 7, 2020

April 6, 2025

Company Information

Applicant Company

Sandoz Gmbh

Biochemiestraβe 10, 6250 Kundl, Austria

Manufacturing Company

Verovskova 57,1526 Ljubljana

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯沙坦钾片 - NMPA 批准文号 | MedPath